Standard
The IMPACT Trial : Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety. / Lipson, D. A.; Criner, G.; Dransfield, M. T.; Halpin, D. M. G.; Han, M. K.; Jones, C. E.; Kilbride, S.; Lange, P.; Lomas, D. A.; Martinez, F. J.; Pascoe, S.; Singh, D.; Wise, R. A.
I:
American Journal of Respiratory and Critical Care Medicine, Bind 199, Nr. A3334, B45, 2019.
Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt
Harvard
Lipson, DA, Criner, G, Dransfield, MT, Halpin, DMG, Han, MK, Jones, CE, Kilbride, S
, Lange, P, Lomas, DA, Martinez, FJ, Pascoe, S, Singh, D & Wise, RA 2019, '
The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety',
American Journal of Respiratory and Critical Care Medicine, bind 199, nr. A3334, B45. <
https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A3334>
APA
Lipson, D. A., Criner, G., Dransfield, M. T., Halpin, D. M. G., Han, M. K., Jones, C. E., Kilbride, S.
, Lange, P., Lomas, D. A., Martinez, F. J., Pascoe, S., Singh, D., & Wise, R. A. (2019).
The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety.
American Journal of Respiratory and Critical Care Medicine,
199(A3334), [B45].
https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A3334Vancouver
Lipson DA, Criner G, Dransfield MT, Halpin DMG, Han MK, Jones CE o.a. The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety. American Journal of Respiratory and Critical Care Medicine. 2019;199(A3334). B45.
Author
Lipson, D. A. ; Criner, G. ; Dransfield, M. T. ; Halpin, D. M. G. ; Han, M. K. ; Jones, C. E. ; Kilbride, S. ; Lange, P. ; Lomas, D. A. ; Martinez, F. J. ; Pascoe, S. ; Singh, D. ; Wise, R. A. / The IMPACT Trial : Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety. I: American Journal of Respiratory and Critical Care Medicine. 2019 ; Bind 199, Nr. A3334.
Bibtex
@article{c54d98301ce744ec8e6eaa19acbcef6d,
title = "The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety",
author = "Lipson, {D. A.} and G. Criner and Dransfield, {M. T.} and Halpin, {D. M. G.} and Han, {M. K.} and Jones, {C. E.} and S. Kilbride and P. Lange and Lomas, {D. A.} and Martinez, {F. J.} and S. Pascoe and D. Singh and Wise, {R. A.}",
year = "2019",
language = "English",
volume = "199",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "A3334",
}
RIS
TY - ABST
T1 - The IMPACT Trial
T2 - Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety
AU - Lipson, D. A.
AU - Criner, G.
AU - Dransfield, M. T.
AU - Halpin, D. M. G.
AU - Han, M. K.
AU - Jones, C. E.
AU - Kilbride, S.
AU - Lange, P.
AU - Lomas, D. A.
AU - Martinez, F. J.
AU - Pascoe, S.
AU - Singh, D.
AU - Wise, R. A.
PY - 2019
Y1 - 2019
M3 - Conference abstract in journal
VL - 199
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
SN - 1073-449X
IS - A3334
M1 - B45
ER -
